|
|
Volumn 56, Issue 10, 2001, Pages 989-992
|
|
Safety of sublingual immunotherapy with monomeric allergoid in adults: Multicenter post-marketing surveillance study
a
a
b
c
c
d
d,e
c
Lofarma SpA
(Italy)
|
|
Author keywords
Post marketing surveillance; Safety; Side effects; Sublingual immunotherapy
|
|
Indexed keywords
ALLERGEN;
ALLERGOID;
LAIS;
UNCLASSIFIED DRUG;
ADULT;
ANAPHYLAXIS;
ARTICLE;
ASTHMA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG SAFETY;
EYE DISEASE;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL SYMPTOM;
HOSPITALIZATION;
HUMAN;
IMMUNOTHERAPY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RESPIRATORY TRACT ALLERGY;
RHINITIS;
TONGUE DISEASE;
URTICARIA;
ADMINISTRATION, SUBLINGUAL;
ADOLESCENT;
ADULT;
ALLERGENS;
DESENSITIZATION, IMMUNOLOGIC;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PLANT EXTRACTS;
PRODUCT SURVEILLANCE, POSTMARKETING;
RESPIRATORY HYPERSENSITIVITY;
TABLETS;
TREATMENT OUTCOME;
|
|
EID: 0034853182
PISSN: 01054538
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1398-9995.2001.00181.x Document Type: Article |
|
Times cited : (76)
|
|
References (10)
|
